Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Sci-Tech Today
sci-tech-today.com-tech-today.com

Zscaler Q4 Fiscal 2026 Earnings: Revenue Beats $898.2 Million

6+ day, 3+ hour ago   (194+ words) The quarter was a clear numerical beat across earnings, revenue, ARR, and near-term guidance. The central investor debate was not Q4 execution but the deceleration implied by the FY2027 revenue and ARR outlook, particularly after a fiscal 2026 period that benefited in part…...

Sci-Tech Today
sci-tech-today.com-tech-today.com

Cango Inc. Q2 2026 Earnings: Revenue Misses $50.8 Million as Mining Restructuring Drives $81.6 Million Loss

1+ week, 5+ day ago   (282+ words) The company entered the digital-asset business in November 2024 and has since pursued mining-scale deployment and infrastructure diversification. As of August 31, 2026, Cango’s reported market capitalization was approximately $98 million–$100 million, while the company had a negative trailing P/E ratio because it…...

Sci-Tech Today
sci-tech-today.com-tech-today.com

Zoomd Technologies Q2 2026 Earnings: Revenue Misses $7.7 Million, but Profitability Rebounds

1+ week, 5+ day ago   (418+ words) Overall, the results indicate revenue growth, lower operating costs, improved profitability, and a strong balance sheet position during Q2 2026. “This quarter reflects a clear improvement in our operating performance, with revenues increasing by 11% compared with Q1.2026, supported by positive operating income and…...

Sci-Tech Today
sci-tech-today.com-tech-today.com

BioLineRx Q2 2026 Earnings: Revenue Meets $0.3 Million as GLIX1 Advances

1+ week, 5+ day ago   (348+ words) BioLineRx reported a Q2 2026 net loss of $4.3 million and basic/diluted loss per ordinary share rounded to $0.00, on revenue of $0.3 million, unchanged year over year. Shares were reported up 4.49% to $2.675 in recent trading after the release, following prior financing-related pressure. BioLineRx’s…...

Sci-Tech Today
sci-tech-today.com-tech-today.com

NetEase Q2 2026 Earnings: Revenue Beats RMB30.1 Billion, but Profit Miss Sends NTES Lower

3+ week, 2+ day ago   (377+ words) NetEase reported Q2 2026 revenue of RMB30.1 billion ($4.4 billion), up 7.9% year over year and above consensus, while non-GAAP diluted EPS was RMB12.02 per ADS ($1.77), below estimates. The earnings miss—largely tied to investment losses—overshadowed stronger gaming margins, and NTES fell about 5.9% in regular…...

Sci-Tech Today
sci-tech-today.com-tech-today.com

InspireMD Q2 2026 Earnings: Revenue Misses $1.77 Million Estimate

3+ week, 3+ day ago   (389+ words) InspireMD reported a Q2 2026 net loss of $0.17 per share, narrowly beating the expected $0.18 loss, while revenue of $1.77 million missed the $2.54 million consensus forecast. Shares traded lower after the release, reflecting the revenue shortfall and the ongoing U.S. CGuard Prime delivery-system recall. InspireMD,…...

Sci-Tech Today
sci-tech-today.com-tech-today.com

Baidu Q2 2026 Earnings: Revenue Misses RMB31.3 Billion as AI Growth Meets Advertising Pressure

3+ week, 3+ day ago   (415+ words) Baidu reported Q2 2026 GAAP diluted EPS of RMB5.74 ($0.85), and non-GAAP diluted EPS of RMB7.22 ($1.06), while revenue fell 4% year over year to RMB31.3 billion ($4.62 billion). Results missed consensus expectations, and BIDU shares sold off sharply, declining 12.74% in the August 18 regular trading session. Baidu missed available…...

Sci-Tech Today
sci-tech-today.com-tech-today.com

XP Inc. Q2 2026 Earnings: Revenue Beats at R$5.06 Billion

3+ week, 5+ day ago   (282+ words) In the latest XP Inc. Q2 2026 Earnings report, XP Inc. reported adjusted diluted EPS of R$2.67, up 9% year over year, on R$5.06 billion of gross revenue, up 8%. Both earnings and revenue exceeded reported consensus expectations, but shares fell 0.76% in regular trading…...